EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Short-Term (+)-JQ1 Exposure on Mouse Aorta: Unanticipated Inhibition of Smooth Muscle Contractility

Binjie Yan, Yu Gui, Yanan Guo, Jiaxing Sun, Mahmoud Saifeddine, Jingti Deng, Joseph A Hill, Morley D Hollenberg iD, Zhi-Sheng Jiang, Xi-Long Zheng iD

Cells · 2023

DOI: 10.3390/cells12111461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Binjie Yan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Biochemistry & Molecular Biology and Physiology & Pharmacology, Libin Cardiovascular Institute, Cumming School of Medicine, The Univer…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(+)-JQ1, a specific chemical inhibitor of bromodomain and extraterminal (BET) family protein 4 (BRD4), has been reported to inhibit smooth muscle cell (SMC) proliferation and mouse neointima formation via BRD4 regulation and modulate endothelial nitric oxide synthase (eNOS) activity. This study aimed to investigate the effects of (+)-JQ1 on smooth muscle contractility and the underlying mechanisms. Using wire myography, we discovered that (+)-JQ1 inhibited contractile responses in mouse aortas with or without functional endothelium, reducing myosin light chain 20 (LC20) phosphorylation and relying on extracellular Ca2+. In mouse aortas lacking functional endothelium, BRD4 knockout did not alter the inhibition of contractile responses by (+)-JQ1. In primary cultured SMCs, (+)-JQ1 inhibited Ca2+ influx. In aortas with intact endothelium, (+)-JQ1 inhibition of contractile responses was reversed by NOS inhibition (L-NAME) or guanylyl cyclase inhibition (ODQ) and by blocking the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) pathway. In cultured human umbilical vein endothelial cells (HUVECs), (+)-JQ1 rapidly activated AKT and eNOS, which was reversed by PI3K or ATK inhibition. Intraperitoneal injection of (+)-JQ1 reduced mouse systolic blood pressure, an effect blocked by co-treatment with L-NAME. Interestingly, (+)-JQ1 inhibition of aortic contractility and its activation of eNOS and AKT were mimicked by the (−)-JQ1 enantiomer, which is structurally incapable of inhibiting BET bromodomains. In summary, our data suggest that (+)-JQ1 directly inhibits smooth muscle contractility and indirectly activates the PI3K/AKT/eNOS cascade in endothelial cells; however, these effects appear unrelated to BET inhibition. We conclude that (+)-JQ1 exhibits an off-target effect on vascular contractility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesMiceHumansAnimalsNG-Nitroarginine Methyl EsterNuclear ProteinsTranscription FactorsAortaMuscle, SmoothPhosphatidylinositol 3-KinaseHuman Umbilical Vein Endothelial CellsCell Cycle ProteinsBromodomain Containing Proteins

Stichwörter der Autor:innen

(+)-JQ1calciumcontractilityeNOSsmooth muscle cell

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesNG-Nitroarginine Methyl EsterNuclear ProteinsTranscription FactorsPhosphatidylinositol 3-KinaseCell Cycle ProteinsBRD4 protein, humanBromodomain Containing Proteins

Autor:innen und Institutionen

  • Departments of Biochemistry & Molecular Biology and Physiology & Pharmacology, Libin Cardiovascular Institute, Cumming School of Medicine, The University of Calgary, 3330 Hospital Drive N.W., Calgary, AB T2N 4N1, Canada.
  • Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerosis of Hunan Province, Hengyang Medical College, University of South China, Hengyang 421001, China.
  • Department of Physiology & Pharmacology, Cumming School of Medicine, The University of Calgary, 3330 Hospital Drive N.W., Calgary, AB T2N 4N1, Canada.
  • Department of Internal Medicine (Cardiology), University of Texas Southwestern Medical Center, Dallas, TX 75390-8573, USA.

ORCID-Profile: Morley D Hollenberg, Xi-Long Zheng

Förderung

  • CIHR
  • Canadian Institutes of Health Research
  • Natural Sciences and Engineering Research Council of Canada
  • CSC Studentship
  • Songlin scholarship at the University of South China

Zitieren

APA

Yan, B., Gui, Y., Guo, Y., Sun, J., Saifeddine, M., Deng, J., Hill, J. A., Hollenberg, M. D., Jiang, Z. S., & Zheng, X. L. (2023). Impact of Short-Term (+)-JQ1 Exposure on Mouse Aorta: Unanticipated Inhibition of Smooth Muscle Contractility. Cells. https://doi.org/10.3390/cells12111461

Vancouver

Yan B, Gui Y, Guo Y, Sun J, Saifeddine M, Deng J, et al. Impact of Short-Term (+)-JQ1 Exposure on Mouse Aorta: Unanticipated Inhibition of Smooth Muscle Contractility. Cells. 2023. doi:10.3390/cells12111461

BibTeX
@article{Yan2023,
  author = {Yan, Binjie and Gui, Yu and Guo, Yanan and Sun, Jiaxing and Saifeddine, Mahmoud and Deng, Jingti and Hill, Joseph A and Hollenberg, Morley D and Jiang, Zhi-Sheng and Zheng, Xi-Long},
  title = {Impact of Short-Term (+)-JQ1 Exposure on Mouse Aorta: Unanticipated Inhibition of Smooth Muscle Contractility},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12111461}
}
Kostenlos starten →